We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

High Blood Pressure in African Americans

Barry J. Materson
Arch Intern Med. 2003;163(5):521-522. doi:10.1001/archinte.163.5.521.
Text Size: A A A
Published online


TREATMENT OF elevated blood pressure has been shown to reduce the risk of death and disability for groups of patients with hypertension. However, because we have not yet learned how to focus our prevention and treatment efforts on the individual patients most likely to experience the negative health consequences, we treat millions of people at relatively low risk of serious consequences so as not to miss treating those at high risk.

Elaboration of the human genome has resulted in the discovery of many polymorphisms of specific human genes related to the pathophysiology of hypertension and holds the promise of a method to identify those people most at risk. Unfortunately, the important discoveries made to date apply only to a very small number of people. Combinations of gene polymorphisms such as reported by Staessen et al1 show potential, but this work is extraordinarily time-consuming, and the findings may not apply to people outside of the specific population studied. The new science of pharmacogenomics will likely help us to be more specific in our drug therapy for patients with hypertension, but it does not yet provide the ability to focus on individual patient risks.2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Hemorrhagic Stroke?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Quick Reference